Home
About MS
About Us
Fundraising and Events
- - 2019 Proposal for funding of oncology, multiple sclerosis and respiratory treatments
    August 14th,2019 Comments are off
  - Member Lunch’s
    August 3rd,2019 Comments are off
- 2019 Proposal for funding of oncology, multiple sclerosis and respiratory treatments
  
  August 14, 2019 by mswanga
  
  Consultation for the funding of Ocrelizumab for Relapsing Remitting MS Pharmac announced yesterday, Wednesday 7th August, that they are now publicly consulting on the proposed funding of Ocrelizumab for RRMS. MSNZ welcomes this announcement which we have been advocating for since May 2017. To read more about our work in this area and our submissions made please see here: https://www.msnz.org.nz/ocrevus-ocrelizumab/ Funding would be available from 1 December 2019 and would be subject to the current criteria for access and exit as the other funded MS treatments. For more information about this please see the attached document. MSNZ will be making a submission to Pharmac and continue to highlight the following areas: – Advocating to make the treatment available before 1 December due to the increasing urgency of many people to switch treatments. – Requesting that the application and review process for switching can begin prior to 1 December to reduce further delay. – Increasing access by making ...
  
  find out more
Information
Contact

Join MS Wanganui

To become a member of MS Wanganui, just download the subscription form below, and return it to us, along with the subscription fee.

Subscription Form

Join Our Community – Sign up for our newsletter

Disclaimer
The views and opinions expressed in this newsletter/website may not necessarily be the views and opinions of Multiple Sclerosis Wanganui Society (Inc) or its members. Information presented has been prepared using sources believed by the author to be reliable and accurate. However the author makes no guarantee or assumes no legal liability or responsibility for the accuracy, omissions or completeness of any information presented including any links to other websites. The author accepts no responsibility for decisions made by readers
.

A SPECIAL THANKS TO THE FOLLOWING ORGANISATIONS FOR THEIR CONTINUED SUPPORT!